undamentalytics Newsletter
Sign in

Clover Health Investments, Corp. cash flow statement

In fiscal 2025, Clover Health Investments, Corp.'s operations generated −$66.9m of cash; it spent $2.0m on capital projects, leaving free cash flow of −$69.0m. It returned $18.3m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−160−118−282−204−14535−6777
Depreciation and amortisation−3−00−2−4−3−20
Stock-based pay3716416414111410472
Capital spending01141223
Free cash flow−160−119−283−208−14533−6974
Free cash flow after stock pay−163−126−447−373−286−81−1732
Share buybacks000002180
Shares issued002840101—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ALHC vs CLOVCLOV vs OSCRCLOV vs MOH

More: Managed Health Care stocks compared, Health Care sector, rankings of US companies

Figures from Clover Health Investments, Corp.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Clover Health Investments, Corp.